Original Research | By Saad M, Fuernau G, Thiele H et al.
AIMS - The aim of the current study was to investigate the impact of a chronic total occlusion (CTO) in a non-infarct-related coronary artery (non-IRA) on one-year mortality and occurrence of cardiac arrhythmia in patients with cardiogenic shock (CS) complicating acute myocardial infarction (AMI). METHODS AND RESULTS - In a retrospective sub-analysis of the Intraaortic Balloon Pump in Cardio...
Original Research | By de Waha S, Schoene K, Thiele H et al.
BACKGROUND - Aim of the current study was to analyse the impact of atrial fibrillation (AF) on prognosis in patients with cardiogenic shock (CS) complicating acute myocardial infarction (AMI), which has never been investigated yet. METHODS - The current analysis is a substudy of the IABP-SHOCK II trial. Patients were grouped according to the presence or absence of AF. The primary endpoint was...
Risk Stratification for Patients in Cardiogenic Shock After Acute Myocardial Infarction
Original Research | By Zeymer U, Werdan K, Thiele H et al.
BACKGROUND - Current guidelines recommend immediate multivessel percutaneous coronary intervention (PCI) in patients with cardiogenic shock, despite the lack of randomised trials. We sought to investigate the use and impact on outcome of multivessel PCI in comparison to culprit lesion only PCI in a retrospective analysis in patients with cardiogenic shock complicating acute myocardial infarction. METHO...
Expert Opinion | By Lloyd-Jones DM, Braun LT, Ndumele CE et al.
Clinical Trial | By DW Park, JM Ahn, SC Yun et al.
BACKGROUND - Comparative outcomes of coronary-artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) for left main coronary artery (LMCA) disease were previously reported. However, data on very long-term (>10 years) outcomes are limited. OBJECTIVE - To compare 10-year outcomes after PCI and CABG for LMCA disease. METHODS - In ...
Review Article | By D Capodanno, F Alfonso, GN Levine et al.
Dual antiplatelet therapy (DAPT) is the cornerstone of pharmacological treatment aimed at preventing the atherothrombotic complications in patients with a variety of coronary artery disease (CAD) manifestations. Prescribers of DAPT are confronted with a number of challenges that include selecting the appropriate P2Y12 inhibitor and determining the optimal duration of DAPT with the scope of minimizing the risk of ischemic...